Abstract
In recent years, much research has been done on genetic links to disease risk and development. The human genome contains thousands of SNPs or single nucleotide polymorphisms. These SNPs account for much of the variance between people; therefore, it makes sense that the SNPs could also reveal the variance in health between people. This chapter delves into common diseases that appear later in life and potential genetic risk factors for the diseases. Recent research has created ties between genome polymorphisms and cancer, cardiovascular health, and mental health. Identification of the polymorphisms could lead to a future of personalized medicine, where a patient’s genome would be used to assess risk of illness and prevent complications to the fullest extent. In some disease states, such as breast cancer, genomic research is already being used clinically to identify women at high risk of development. In other disease states, research is only just beginning to identify genetic loci that could be responsible for development. This chapter is meant to answer the following question: how much of our health can we control, and what role does genetic variation play in disease development?
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
PharmGKB (2016) Accessed Sept 2016. https://www.pharmgkb.org/index.jsp
SNPedia (2016) Accessed Sept 2016. http://www.snpedia.com
American Cancer Society (2016) Lifetime risk of developing or dying from cancer. http://www.cancer.org/cancer/cancerbasics/lifetime-probability-of-developing-or-dying-from-cancer
Common Cancer Types (2016) National Cancer Institute. http://www.cancer.gov/types/common-cancers
Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386
Chenh Y, Jiang T, Zhu M et al (2016) Risk assessment models for genetic risk predictors of lung cancer using two-stage replication for Asian and European populations. Oncotarget 8(33):53959–53967. E-published ahead of print. https://doi.org/10.18632/oncotarget.10403
Xie K, Wang C, Qin N, Yang J et al (2016) Genetic variants in regulatory regions of microRNAs are associated with lung cancer risk. Oncotarget 7(30):47966–47974., E-published ahead of print. https://doi.org/10.18632/oncotarget.10299
El-Zein RA, Young RP, Hopkins RJ, Etzel CL (2012) Genetic predisposition to chronic obstructive pulmonary disease and/or lung cancer: important considerations when evaluating risk. Cancer Prev Res 5(4):522–527. https://doi.org/10.1158/1940-6207.CAPR-12-0042
Lee S, She J, Deng B, Kim J et al (2016) Multiple-level validation identifies PARK2 in the development of lung cancer and chronic obstructive pulmonary disease. Oncotarget 7(28):44211–44223. E-published ahead of print. https://doi.org/10.18632/oncotarget.9954
Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291):1389–1399
Stratton MR, Rahman N (2008) The emerging landscape of breast cancer susceptibility. Nat Genet 40:17–22. https://doi.org/10.1038/ng.2007.53
Kleibl Z, Kristensen VN (2016) Woman at high risk of breast cancer: molecular characteristics, clinical presentation and management. Breast 28:136–144. https://doi.org/10.1016/j.breast.2016.05.006
Pelttari LM et al (2016) RAD51B in familial breast cancer. PLoS One 11(5):E0153788. https://doi.org/10.1371/journal.pone.0153788
What is Prostate Cancer? American Cancer Society (2016). http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-what-is-prostate-cancer
Inherited Risk for Prostate Cancer. Memorial Sloan Kettering Cancer Center (2016). https://www.mskcc.org/cancer-care/risk-assessment-screening/hereditary-genetics/genetic-counseling/inherited-risk-prostate
Teerlink CC et al (2016) Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21. Hum Genet 135(8):923–938. E-published ahead of print. https://doi.org/10.1007/s00439-016-1690-6
Hashemi M et al (2016) Association between ingle nucleotide polymorphism in miR-499, miR-196a2, miR-146a and miR-149 and prostate cancer risk in a sample of Iranian population. J Adv Res 7(3):491–498. https://doi.org/10.1016/j.jare.2016.03.008
Colorectal Cancer (2016) National Cancer Institute. http://www.cancer.gov/types/colorecta
Inherited Risk for Colorectal Cancer. Memorial Sloan Kettering Cancer Center (2016). https://www.mskcc.org/cancer-care/risk-assessment-screening/hereditary-genetics/genetic-counseling/inherited-risk-colorectal
Hahn MM et al (2016) The genetic heterogeneity of colorectal cancer predisposition-guidelines for gene discovery. Cell Oncol 39(6):491–510. E-published ahead of print. https://doi.org/10.1007/s13402-016-0284-6
Zeng C et al (2016) Identification of susceptibility loci and genes for colorectal cancer risk. Gastroenterology 150(7):1633–1645. https://doi.org/10.1053/j.gastro.2016.02.076
National Heart, Lung, and Blood institute (2016) What is Coronary Heart Disease? US Department of Health and Human Services. http://www.nhlbi.nih.gov/health/health-topics/topics/cad#
Hrira MY, Chkioua L, Slimani A et al (2012) Hsp70-2 gene polymorphism: susceptibility implication in Tunisian patients with coronary artery disease. Diagn Pathol 7:88–92
Liu D, Song J, Ji X, Liu Z, Cong M, Hu B (2016) Association of genetic polymorphisms on VEGFA and VEGFR2 with risk of coronary heart disease. Medicine (Baltimore) 95(19):e3413. https://doi.org/10.1097/MD.0000000000003413
Souiden Y et al (2016) MnSOD and GPx1 polymorphism relationship with coronary heart disease risk and severity. Biol Res 49:22. https://doi.org/10.1186/s40659-016-0083-6
Hoeper MM, Bogaard HJ, Condliffe R et al (2013) Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 62(25 Suppl):D42–D50
Liu L, Li Y, Tollefsbol TO (2008) Gene-environment interactions and epigenetic basis of human diseases. Curr Issues Mol Biol 10:25–36
Chelladurai P, Seeger W, Pullamsetti SS (2016) Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives. Eur Respir Rev 25(140):135–140. https://doi.org/10.1183/16000617.0036-2016
Dean M, Hamon Y, Chimini G (2001) The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 42:1007–1017. https://doi.org/10.1101/gr.GR-1649R
Cao XL, Yin RX, Huang F, Wu JZ, Chen WX (2016) Chromosome 9p21 and ABCA1 genetic variants and their interactions on coronary heart disease and ischemic stroke in a Chinese Han population. Int J Mol Sci 17(4):586. https://doi.org/10.3390/ijms17040586
Lee TH et al (2016) Identification of PTCSC3 as a novel locus for large-vessel ischemic stroke: a genome-wide association study. J Am Heart Assoc 4(3):e003003. https://doi.org/10.1161/JAHA.115.003003
Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG (1973) Hyperlipidemia in coronary heart disease. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Investig 52(7):1544–1568. https://doi.org/10.1172/JCI107332
Ripatti P et al (2016) The contribution of GWAS loci in familial dyslipidemias. PLoS Genet 12(5):e1006078. https://doi.org/10.1371/journal.pgen.1006078
Mayo Clinic Staff (2016) Depression (major depressive disorder). The Mayo Clinic, Rochester. http://www.mayoclinic.org/diseases-conditions/depression/basics/causes/con-20032977
Anxiety and Depression Association of America (2016) Facts and Statistics. ADAA, Silver Spring. https://www.adaa.org/about-adaa/press-room/facts-statistics
Jelen AM et al (2015) The influence of C3435T polymorphism of the ABCB1 gene on genetic susceptibility to depression and treatment response in polish population – preliminary report. Int J Med Sci 12(12):974–979. https://doi.org/10.7150/ijms.13119
National Institute of Mental Health (2016) Bipolar disorder among adults. NIMH, Bethesda. http://www.nimh.nih.gov/health/statistics/prevalence/bipolar-disorder-among-adults.shtml
Koefoed P, Andreassen O, Bennike B, Dam H, Djurovic S, Hansen T et al (2011) Combinations of SNPs related to signal transduction in bipolar disorder. PLoS One 6:e23812. https://doi.org/10.1371/journal.pone.0023812
Mellerup E et al (2015) Combinations of genetic data present in bipolar patients, but absent in control persons. PLoS One 10(11):e0143432. https://doi.org/10.1371/journal.pone.0143432
Pihlstrom L, Axelsson G, Bjornara KA, Dizdar N, Fardell C, Forsgren L et al (2013) Supportive evidence for 11 loci from genome-wide association studies in Parkinson’s disease. Neurobiol Aging 34(6):1708 e7–1708 13. https://doi.org/10.1016/j.neurobiolaging.2012.10.019
Shi C, Zheng Z, Wang Q, Wang C et al (2016) Exploring the effects of genetic variants on clinical profiles of Parkinson’s disease assessed by the unified Parkinson’s disease rating scale and Hoehn-Yahr stage. PLoS One 11(6):e0155758. https://doi.org/10.1371/journal.pone.0155758
Kumari U, Tan EK (2009) LRRK2 in Parkinson’s disease: genetic and clinical studies from patients. FEBS J 276(22):6455–6463. https://doi.org/10.1111/j.1742-4658.2009.07344.x
Kumaran R, Cookson MR (2015) Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson’s disease. Hum Mol Genet 24(R1):R32–R44. https://doi.org/10.1093/hmg/ddv236
Ran C, Brodin L, Forsgren L, Westerlund M et al (2016) Strong Associatin between glucocerebrosidase mutations and Parkinson’s disease is Sweden. Neurobiol Aging 45:212.e5–212.e11. E-published ahead of print. https://doi.org/10.1016/j.neurobiolaging.2016.04.022
DeMattos RB, Cirrito JR et al (2004) ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41:193–202
US National Library of Medicine (2016) APOE: Apolipoprotein E. Genetics Home Reference. https://ghr.nlm.nih.gov/gene/APOE#conditions
Lambert JC, Heath S et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41:1094–1099
Kang SS, Kurti A, Wojtas A, Baker KE et al (2016) Identification of plexin A4 as a novel clusterin receptor links two Alzheimer’s disease risk genes. Hum Mol Genet 25(16):3467–3475. E-published ahead of print. https://doi.org/10.1093/hmg/ddw188
Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait. Arch Gen Psychiatry 60:1187–1192
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421–427
Rohde PD et al (2016) Covariance association test (CVAT) identify genetic markers associated with schizophrenia in functionally associated biological processes. Genetics 203(4):1901–1913. E-Published ahead of print. https://doi.org/10.1534/genetics.116.189498
Lamantia AS (1999) Forebrain induction, retinoic acid, and vulnerability to schizophrenia: insights from molecular and genetic analysis in developing mice. Biol Psychiatry 46:19–30
Park SJ, Lee JY et al (2015) Toll-like receptor 2 deficiency induces schizophrenia-like behaviors in mice. Sci Rep 5:8502. https://doi.org/10.1038/srep08502
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Broadwater, A., Pathak, Y. (2018). Living Between Sickness and Health: Where Is the Human Genome Leading Us?. In: Pathak, Y. (eds) Genomics-Driven Healthcare. Adis, Singapore. https://doi.org/10.1007/978-981-10-7506-3_2
Download citation
DOI: https://doi.org/10.1007/978-981-10-7506-3_2
Published:
Publisher Name: Adis, Singapore
Print ISBN: 978-981-10-7505-6
Online ISBN: 978-981-10-7506-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)